login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
Myovant Sciences Ltd (MYOV) Stock News
USA
-
New York Stock Exchange
- NYSE:MYOV -
BMG637AM1024
-
Common Stock
26.98
USD
-0.01 (-0.04%)
Last: 3/9/2023, 8:04:00 PM
26.98
USD
0 (0%)
After Hours:
3/9/2023, 8:04:00 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
MYOV Latest News, Press Relases and Analysis
All
Press Releases
2 years ago - By: Pomerantz LLP
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences, Ltd. - MYOV
2 years ago - By: Pomerantz LLP
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences, Ltd. - MYOV
2 years ago - By: Pomerantz LLP
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences, Ltd. - MYOV
2 years ago - By: Pomerantz LLP
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences, Ltd. - MYOV
2 years ago - By: Pomerantz LLP
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences, Ltd. - MYOV
2 years ago - By: Pomerantz LLP
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences, Ltd. - MYOV
3 years ago - By: Benzinga
Myovant Sciences: Q2 Earnings Insights
3 years ago - By: Benzinga
Where Myovant Sciences Stands With Analysts
3 years ago - By: Seeking Alpha
Myovant Sciences GAAP EPS of -$0.56 beats by $0.08, revenue of $100.23M misses by $2.13M (NYSE:MYOV)
3 years ago - By: Myovant Sciences, Inc.
Myovant Sciences Announces Corporate Updates and Financial Results for Third Fiscal Quarter 2022
3 years ago - By: Kahn Swick & Foti, LLC
MYOVANT SCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Myovant Sciences - MYOV
3 years ago - By: Kahn Swick & Foti, LLC
MYOVANT SCIENCES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Myovant Sciences - MYOV
3 years ago - By: Julie & Holleman LLP
MYOV SPECIAL ALERT: Julie & Holleman Investigates Potential Legal Claims Related to Take-Private Acquisition of Myovant Sciences
3 years ago - By: Myovant Sciences, Inc.
Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08
3 years ago - By: Myovant Sciences, Inc.
Myovant Sciences Appoints Ann Tomlin as Senior Vice President of Human Resources
3 years ago - By: Myovant Sciences, Inc.
Myovant Sciences Announces Corporate Updates and Financial Results for Second Fiscal Quarter 2022
3 years ago - By: Kahn Swick & Foti, LLC
MYOVANT SCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Myovant Sciences - MYOV
3 years ago - By: Weiss Law
SHAREHOLDER ALERT: Weiss Law Investigates Myovant Sciences Ltd.
Please enable JavaScript to continue using this application.